Clinical Trials Logo

Clinical Trial Summary

Pseudohypoparathyroidism type 1a (PHP1a) is a rare disease that causes childhood obesity and learning difficulties. This study will investigate eating behaviors and perform cognitive testing on children with PHP1a. The investigators will compare their results to those of healthy siblings and other obese children.


Clinical Trial Description

Pseudohypoparathyroidism type 1a (PHP1a) is a genetic disorder that causes early-onset, syndromic obesity and cognitive impairment. This study aims to evaluate eating behaviors, cognition and executive function in children with PHP1a, compared with healthy siblings and matched obese controls. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02411461
Study type Observational
Source Vanderbilt University Medical Center
Contact
Status Completed
Phase
Start date December 1, 2014
Completion date January 2017

See also
  Status Clinical Trial Phase
Recruiting NCT03029429 - Theophylline Treatment for Pseudohypoparathyroidism Phase 2
Recruiting NCT04969926 - Natural History Study of Parathyroid Disorders
Enrolling by invitation NCT04240821 - Theophylline for Treatment of Pseudohypoparathyroidism Phase 2
Completed NCT00004661 - Study of the Regulation of Parathyroid Hormone Secretion in Pseudohypoparathyroidism N/A
Recruiting NCT05945576 - IDMet (RaDiCo Cohort) (RaDiCo-IDMet)
Active, not recruiting NCT02551120 - Characterization of Patients With Non-surgical Hypoparathyroidism and Pseudohypoparathyroidism
Recruiting NCT04551170 - Theophylline Treatment for Pseudohypoparathyroidism - Children 2-12 Years Old Phase 2
Completed NCT00001242 - Studies of States With Resistance to Vitamin D and Parathyroid Hormone
Active, not recruiting NCT00497484 - Evaluation of rhGH Replacement Therapy in Patients With Pseudohypoparathyroidism Type Ia (PHP Ia) N/A